Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 12;10(6):164.
doi: 10.3390/tropicalmed10060164.

Bacterial Pathogens and Antibiotic Resistance in Bloodstream Infections in Tunisia: A 13-Year Trend Analysis

Affiliations

Bacterial Pathogens and Antibiotic Resistance in Bloodstream Infections in Tunisia: A 13-Year Trend Analysis

Lamia Kanzari et al. Trop Med Infect Dis. .

Abstract

The antimicrobial resistance (AMR) surveillance network has been monitoring bloodstream bacterial pathogens and their resistance since 1999 in Tunisia. We report the long-term trends in the distribution of bloodstream bacterial pathogens and their resistance patterns from this surveillance database. We analyzed antibiotic resistance rates in 11 tertiary teaching hospital laboratories under the AMR surveillance network during 2011-2023, focusing on six priority bacterial pathogens, using the Cochrane-Armitage test for trend analysis. Of 22,795 isolates, K. pneumoniae (38.5%) was the most common, followed by S. aureus (20.4%), E. coli (13.6%), and A. baumannii (10.3%). Carbapenem resistance was highest in A. baumannii (77%), followed by Pseudomonas aeruginosa (29.3%), K. pneumoniae (19.4%), and Enterobacter cloacae (6.8%). Carbapenem-resistant Enterobacterales and third-generation cephalosporin-resistant Enterobacterales (3GCREB) increased from 10.6% to 26.3% (p-value < 0.001), and from 39% to 50.2%, respectively, during 2011-2023 (p-value < 0.001). Vancomycin resistance (38.3%) and the emergence of linezolid resistance in 2019 (2.4%) were reported in E. faecium isolates. Resistance to carbapenems and 3GC is a major challenge to controlling BSI in Tunisia. The national AMR surveillance network helps monitor annual patterns and guides empirical therapy. An integrated database combining clinical profiles and resistance data via real-time data-sharing platforms could improve clinical decision-making.

Keywords: GLASS; SORT-IT; antimicrobial resistance surveillance; carbapenem resistant Enterobacterales; operational research.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Trends in the number of blood-culture-positive bacterial isolates and the distribution of Gram-positive and Gram-negative isolates from the antimicrobial resistance sentinel surveillance laboratories in Tunisia, 2011–2023.
Figure 2
Figure 2
Trends in the distribution of the type of bacterial pathogens among blood-culture-positive bacterial isolates from the antimicrobial resistance sentinel surveillance laboratories in Tunisia, 2011–2023.
Figure 3
Figure 3
Proportion of blood-culture-positive bacterial isolates resistant to selected antibiotics by the type of pathogen (ESKAPE) from the antimicrobial resistance sentinel surveillance laboratories in Tunisia, 2011–2023. Abbreviation: ampicillin (AMP); amoxicillin-clavulanic acid (AMC); piperacillin–tazobactam (PTZ); cefotaxime (CTX); ceftazidime (CAZ); imipenem (IMP); gentamicin (GEN); gentamicin high-charged 30 µg (GHC); amikacin (AMK); ciprofloxacin (CIP); ofloxacin (OFL); oxacillin (OXA); vancomycin (VAN); teicoplanin (TEI), linezolid (LIN).
Figure 4
Figure 4
Trends in the proportion of positive bacterial isolates resistant to selected antibiotics by the type of pathogen (ESKAPE) from the antimicrobial resistance sentinel surveillance laboratories in Tunisia, 2011–2023. Abbreviation: amoxicillin-clavulanic acid (AMC); cefotaxime (CTX); imipenem (IMP); gentamicin (GEN); amikacin (AMK); ciprofloxacin (CIP); ofloxacin (OFL); oxacillin (OXA); vancomycin (VAN); teicoplanin (TEI); ampicillin (AMP); gentamicin high-charged 30 µg (GHC); linezolid (LIN).

References

    1. Stewardson A.J., Allignol A., Beyersmann J., Graves N., Schumacher M., Meyer R., Tacconelli E., De Angelis G., Farina C., Pezzoli F., et al. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: A multicentre retrospective cohort study. Eurosurveillance. 2016;21:30319. doi: 10.2807/1560-7917.ES.2016.21.33.30319. - DOI - PMC - PubMed
    1. WHO Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed. [(accessed on 26 November 2023)]. Available online: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-....
    1. Marchello C.S., Dale A.P., Pisharody S., Rubach M.P., Crump J.A. A Systematic Review and Meta-analysis of the Prevalence of Community-Onset Bloodstream Infections among Hospitalized Patients in Africa and Asia. Antimicrob. Agents Chemother. 2019;64:e01974-19. doi: 10.1128/AAC.01974-19. - DOI - PMC - PubMed
    1. Diekema D.J., Hsueh P.-R., Mendes R.E., Pfaller M.A., Rolston K.V., Sader H.S., Jones R.N. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 2019;63:e00355-19. doi: 10.1128/AAC.00355-19. - DOI - PMC - PubMed
    1. Murray C.J.L., Ikuta K.S., Sharara F., Swetschinski L., Aguilar G.R., Gray A., Han C., Bisignano C., Rao P., Wool E., et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;399:629–655. doi: 10.1016/S0140-6736(21)02724-0. - DOI - PMC - PubMed

LinkOut - more resources